Navigation Links
AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate
Date:1/12/2009

AIM Pharmakon introduced next generation of health and longevity products with a unique premium quality natural liquid calcium & mineral supplement concentrate. AimCa++DONAN is ideal for the market segments of athletes, women in pre and post-menopausal phases, baby-boomers, and seniors needing extra calcium supplementation. The innovative products of Aim Pharmakon are highly efficacious and an exceptionally high-benefit-to-cost ratio for consumers. API and Global Life Science, LLC USA have a strategic partnership in marketing, project development and project management and Global Life Science will promote AimCa++DONAN (TM) and AimEndurance (TM) globally.

(Vocus) January 12, 2009 -- AIM Pharmakon, Inc. (API), a New York-based company, announced today the introduction of the next generation of health and longevity products with AimCa++DONAN (TM), a new premium quality liquid calcium mineral concentrate for bone development. The product is available directly from AIM Pharmakon, Inc., through the physician care market, in select retail outlets and through its affiliated company Global Life Science, LLC USA. The key components of the product are derived through "Green Technology". The product is eco-friendly, completely natural with specific biophysiological features, bioavailable nutrients, and biodegradable components. Unique product features are- no preservatives, no artificial colors and no artificial flavors. AimCa++DONAN is ideal for the market segments of athletes, women in pre and post-menopausal phases, baby-boomers, and seniors needing extra calcium supplementation.



"The role of calcium in the pathogenesis of osteoporosis is significantly prominent. There is insufficient intake of dietary calcium and mineral in our diet, particularly in those with an active lifestyle. The high prevalence of osteoporosis, bone and dental related diseases are observed in geographical regions with high dairy consumption. Proteins in dairy calcium sources aid in elevating the blood's acidic value. That leads to leaching of calcium from bones thereby weakening the bones. A high protein diet alarmingly aggravates the reduction in bone density. Additionally, lactose intolerance can limit the options of getting calcium from dairy sources. This product is formulated to address this set of challenges. AimCa++DONAN (TM) is a non-acidic, non-diary, and non-protein source of calcium for bone and dental health. The alkaline nature of the product ensures that it is gentle on gastro-intestinal tract for people with GERD," commented Vijay Puntambekar, President of AIM Pharmakon.

AimCa++DONAN (TM) in a liquid concentrate matrix is the product of choice due to its efficacy, ease of intake, high bioavailability, and palatability," commented Vijay Puntambekar. AimCa++DONAN (TM) contains DONAN (TM) from Coral International Co., Ltd., Japan, which has exceptionally high elemental calcium content, essential minerals and trace mineral profile contributing to elevated mineral availability. Recent studies in Japan have shown that aragonite-type calcium of coral origin is better absorbed through the intestine than calcium of calcium carbonate origin. The product has a low glycemic value and is suitable for people with diabetes. This product contains Nuti-Masu from Nuchi Masu Co., Ltd, a sea-salt mineral and SunSea ionized mineral complex from Coral International, Co., Ltd. Both are exclusive, high-end, premium-quality ingredients from Japan incorporating the form of a proprietary bioenhancing AIMix Sorb mix. The synergistic balance of minerals and soluble fiber helps achieve the optimum bone health advantages of AimCa++DONAN (TM) along with a balanced diet and exercise.

"The innovative products of Aim Pharmakon will continue to be highly efficacious and an exceptionally high-benefit-to-cost ratio for athletes, women, baby-boomers, and seniors," added Vijay Puntambekar. "We are proud to be recognized for developing preservative-free, hard-to-formulate products. API made significant strides in addressing the specific supplement needs for active lifestyles, seniors and people with challenged immunity levels. Our core competence and aim is: Formulating Innovation," he continued.

API develops and markets preservative-free, natural products in compact dosage forms. The company was incorporated in 2005 and has in-house R&D capability and a US FDA registered manufacturing facility. The company is also launching an ultra-premium, completely natural and preservative-free cosmetic product line for the Japanese market. It will include specialty hair care and skin care beauty products. AIM Pharmakon offers diversified services in product development and project management in the areas of pharmaceuticals, natural products, consulting, and has offices in Long Island, New York, Tokyo and Mumbai.

API and Global Life Science, LLC USA- GLS have a strategic partnership in marketing, project development and project management. GLS brand products are sold in United States and offered for select African and Middle Eastern countries on an exclusivity basis. API and Global Life Science USA have an impressive array of efficacious products, including supportive dietary supplements for HIV/AIDS. Global Life Science will promote AimCa++DONAN (TM) and AimEndurance (TM), for overall cardiovascular health, globally.

###

Read the full story at http://www.prweb.com/releases/aimpharmakon/globallifescienceusa/prweb1845464.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Push-to-Connect In-Line Filters Introduced
2. Managed Compliance Services Program (MCSP) Introduced for Small Healthcare Practitioners
3. New Stretch Mark and Skin Rejuvenation Treatment Introduced to Houston by Dr. Zaniewski-Singh
4. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
5. Groundbreaking Sign Chi Do Stress Management System Introduced by Dr. Anne Borik Now Available to the Public
6. "Campus Alert by VoiceGate" introduced at Internet Telephony(R) Conference and Expo
7. Arizona Patient Protection Act Introduced
8. Chicken pox vaccination should be introduced for children in the UK
9. New Ovarian Cancer Biomarker Research Act Introduced
10. New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced
11. National CPR/AED Awareness Week Introduced in Congress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate
(Date:5/26/2016)... ... 26, 2016 , ... MadgeTech will be showcasing its line of data ... Hampshire at the MadgeTech headquarters. With products sold in more than 100 countries around ... including NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... Retinal Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, ... the public. , Dr. Maisel, founder of Retina Group of New York ...
(Date:5/26/2016)... ... ... to provide hair restoration information to the widest possible audience, Dr. Parsa Mohebi is making ... app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making all of his ... says, “The positive response to the Snapchat videos we started last month has been overwhelming. ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... of healthcare supply chain solutions, today announced the organization has earned its ISO ... international standards and is compliant with all rules and policies associated with ISO ...
(Date:5/26/2016)... Tampa, Fla. (PRWEB) , ... May 26, 2016 , ... ... Center (AHEC) to host a six-week smoking cessation class starting June 6 at their ... AHEC’s website, http://www.gnahec.org . , Additionally, the Lung Institute has created a free ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... -- TARE (Transarterial Radio-embolization) Using Yttrium-90 ... Overall Decreased Use of Hospital Resource ... healthcare company, has today announced the publication of ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research), ... yttrium-90 glass microspheres is associated with cost savings ...
(Date:5/25/2016)... 2016 According to a new ... 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by ... Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021", published ... Market for the forecast period of 2016 to 2021. ... by 2021 from USD 117.3 Million in 2016, at ...
Breaking Medicine Technology: